The Continuous Renal Replacement Therapy Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for Continuous Renal Replacement Therapy has seen a considerable increase in recent times. The market, which was valued at $1.57 billion in 2024, is projected to expand to $1.74 billion in 2025, growing at a Compound Annual Growth Rate (CAGR) of 11.3%.
The Continuous Renal Replacement Therapy market is anticipated to expand to a size of $2.64 billion by 2029. This growth represents a compound annual growth rate (CAGR) of 10.9%.
Download Your Free Sample of the 2025 Continuous Renal Replacement Therapy Market Report and Uncover Key Trends Now!The drivers in the continuous renal replacement therapy market are:
• Increased demand for advanced Continuous Renal Replacement Therapy devices
• Rising incidents of acute kidney injury
• Growth in the number of medical applications
• High prevalence of co-morbidities and continuous research and development
The continuous renal replacement therapy market covered in this report is segmented –
1) By Product: System, Consumables
2) By Therapy: Renal, Non-Renal
3) By Modality: Slow Continuous Ultra-Filtration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), Continuous Venovenous Hemodiafiltration (CVVHDF)
4) By Age Group: Adults, Pediatrics Or Neonates
5) By End-Users: Hospitals, Ambulatory Care, Homecare
The trends in the continuous renal replacement therapy market are:
• Rapid advancements and product innovation are beginning to trend in the market.
• There is a rise in the launch of new technologies for continuous renal replacement therapy.
• Technological advancements play a crucial role in shaping the future of the market.
• There is an emerging trend of technologically advanced CRRT products.
The major players in the continuous renal replacement therapy market are:
• Medtronic Plc
• Fresenius Medical Care AG & Co
North America was the largest region in the continuous renal replacement therapy market in 2023